Insider Brief
- Ema, the first AI platform dedicated to women’s health, secured over $3 million in funding, led by Emmeline Ventures, leveraging a proprietary dataset of 10 million interactions to deliver clinically validated assessments and positive health outcomes from puberty to post-menopause.
- Within six months of launch, Ema achieved over $1 million in contract value, partnering with organizations like PatientsLikeMe and Willow, while demonstrating significant impact in areas like perinatal mental health, with 75% of women completing assessments seeking professional support.
- Positioned as a transformative force in women’s health, Ema combines empathy-driven AI and enterprise partnerships to empower women, address critical needs, and improve care delivery on a broad scale.
PRESS RELEASE — Ema, the first agentic AI platform designed to transform women’s health, announced the successful close of its most recent round, bringing total funding to over $3 million. From the start, Ema was trained on a proprietary dataset of 10 million interactions between women and
physicians discussing health and wellness together. Ema then created proprietary functionality for their AI (such as administrating clinically validated assessment) resulting in creating positive health outcomes
from the first period to post menopause. The round was led by Emmeline Ventures, a firm committed to supporting female-led companies, with participation from previous investors Kubera Venture Capital and
Victorum Capital.
La Keisha Landrum Pierre, Managing Partner at Emmeline Ventures, shared her enthusiasm, “We invested in Ema because they are redefining women’s health with a powerful combination of empathy and technology. Ema goes beyond generative AI, offering a trusted partner that understands women’s unique needs. By harnessing clinically sound AI, Ema empowers women (and their families) along with their clinical providers to achieve better outcomes, reshaping how care is delivered for a healthier, happier, and more empowered future.”
In the first six months in market, Ema sold over $1 million in contract value, validating the market’s need for AI-driven women’s health solutions. This funding extension is a precursor to Ema’s anticipated next
round which will fuel continued AI innovation and support of their enterprise clients like such as PatientsLikeMe and Willow.
“Ema has proven its ability to significantly advance women’s health,” said Amanda Ducach, CEO of Ema. “As an example, in perinatal mental health conversations, an impressive 75% of women who took the EPDS depression assessment through Ema sought professional mental health support by booking appointments. Moreover, 34% of women engaging with Ema during the campaign displayed signs of depression, highlighting the critical need for accessible mental health resources. Our platform’s ability to
foster meaningful engagement and connect women to care underscores its transformative impact in addressing mental health challenges on a broad scale.”
With a strong foundation of enterprise contracts and AI leadership, Ema is well-positioned to continue its growth serving women’s health organizations and delivering transformative solutions for women.
— — —
For media inquiries, please contact:
Karishma Patel — [email protected]
Karishma Patel
Ema
[email protected]
Visit us on social media:
LinkedIn
Featured image: Credit: Ema
